Evidence for β3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: Analysis by molecular biological and pharmacological methods

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1367-1373

  Takeda, Masayuki ^a   Obara, Kenji ^a   Mizusawa, Takaki ^a   Tomita, Yoshihiko ^a   Arai, Kei ^a   Tsutsui, Toshiki ^a   Hatano, Akihiko ^a   Takahashi, Kota ^a   Nomura, Shintaro ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 3 PHENOXYPROPYL)AMINO]ETHOXY] N (2 METHOXYETHYL)PHENOXYACETAMIDE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ATENOLOL; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUTOXAMINE; CARBACHOL; DIGOXIGENIN; ISOPRENALINE; RECEPTOR SUBTYPE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MESSENGER RNA; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; BLADDER EPITHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; DETRUSOR MUSCLE; DNA SEQUENCE; DRUG ANTAGONISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; URINALYSIS; BLADDER; DRUG EFFECT; GENETICS; IN SITU HYBRIDIZATION; IN VITRO STUDY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; SMOOTH MUSCLE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGED; BASE SEQUENCE; HUMANS; IN SITU HYBRIDIZATION; ISOMETRIC CONTRACTION; ISOPROTERENOL; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROBES; RNA, MESSENGER; URINARY BLADDER;

EID: 0032588710     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Arch JRS, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C and Wilson S (1984) Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163-165.
2. Arunlakshana O and Schild HO (1959) Some quantitative use of drug antagonists. Br J Pharmacol 14:48-58.
3. Bond RA and Clarke DE (1988) Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α-and β-subtypes. Br J Pharmacol 95:723-729.
4. Berkowitz DE, Nardone NA, Smiley RM, Price DT, Kreutter DK, Fremeau RT and Schwinn DA (1995) Distribution of β3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228.
5. De Ponti F, Gibelli G, Croci T, Arcidiaco M, Crema F and Manara L (1996) Functional evidence of atypical β3-adrenoceptors in the human colon using the β3-selective adrenoceptor antagonist SR 59230A. Br J Pharmacol 117:1374-1376.
6. Evansm BA, Papanioannou VR, Bonazzi VR and Summers RJ (1996) Expression of β3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:210-216.
7. Growocott JW, Hollway B, Green M and Wilson C (1993) Zeneca ZD7114 acts as an antagonist at β3-adrenoceptors in rat isolated ileum. Br J Pharmacol 110:1375-1380.
8. Hirata S, Ito A, Morii E, Wanaka A, Tohyama M, Kitamura Y and Nomura S (1992) Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: An analysis using in situ hybridization histochemistry. Brain Res Mol Brain Res 15:47-54.
9. Hoey J, Jackson CM, Pegg GG and Sillence MN (1996) Characterization of cyanopindolol analogues active at the β3-adrenoceptor in rat ileum. Br J Pharmacol 119:564-568.
10. Kaumann AJ (1996) (-)-CGP 12177-induced increase of human atrial contraction through a putative third β-adrenoceptor. Br J Pharmacol 117:93-98.
11. Kaumann AJ and Molenaar P (1996) Difference between the third cardiac β-adrenoceptor and the colonic β3-adrenoceptor in the rat. Br J Pharmacol 118:2085-2098.
12. Krief S, Lönnqvist F, Raimbault S, Baude B, Spronsen AV, Arner P, Strosberg D, Ricquier D and Emorine LJ (1993) Tissue distribution of β3-adrenoceptor mRNA in man. J Clin Invest 91:344-349.
13. Larsen JJ (1979) α-and β-Adrenoceptors in the detrusor muscle and bladder base of the pig and β-adrenoceptors in the detrusor of man. Br J Urol 65:215-222.
14. Levin RM, Ruggieri MR and Wein AJ (1988) Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J Urol 139:844-848.
15. Li JH, Yasay GD and Kau ST (1986) β-Adrenoceptor subtypes in the detrusor of guinea-pig urinary bladder. Pharmacology 44:13-18.
16. Manara L, Badone D, Naroni M, Boccardi G, Cecchi R, Croci T, Giudice A, Guzzi U, Landi M and Lefur G (1995) Functional identification of rat atypical β3-adrenoceptors by the first β3-selective antagonists, aryloxy-propanolaminotetralins. Br J Pharmacol 117:435-442.
17. Molenaar P, Sarsero D, Arch JRS, Kelly J, Henson SM and Kaumann AJ (1997) Effects of (-)-RO363 at human atrial β-adrenoceptor subtypes, the human cloned β3-adrenoceptor, and rodent intestinal β3-adrenoceptors. Br J Pharmacol 120: 165-176.
18. Morita T, Ando M, Ihara K and Ohshima H (1993) Species differences in cAMP production and contractile response induced by beta-adrenoceptor subtypes in urinary bladder smooth muscle. Neurourol Urodyn 12:185-190.
19. Morita T, Dohkita S, Kondo S, Nishimoto T, Hirano S and Tsuchida S (1990) Cyclic adenosine monophosphate production and contractile response induced by beta-adrenoceptor subtypes in rabbit urinary bladder smooth muscle. Urol Int 45:10-15.
20. Morrison JFB, Nimimo AJ and Whitaker EM (1986) The localization of β3-adrenoceptor subtypes in the rat urinary bladder. J Physiol 38:29P.
21. Nergårdah A, Borés LO and Naglo AS (1977) Characterization of the adrenergic β-receptors in the urinary bladder of man and cat. Acta Pharmacol Toxicol 40:14-21.
22. Pak MD and Fishman PH (1996) Anomalous behavior of CGP12177A on beta1-adrenergic receptors. J Recept Signal Transduct Res 16:1-23.
23. Ponte P, Ng SY, Engel J, Gunning P and Kedes L (1984) Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of human β-actin. Nucleic Acid Res 12:1687-1696.
24. Roberts SJ, Russell FD, Molenaar P and Summers RJ (1995) Characterization and localization of atypical β-adrenoceptors in rat ileum. Br J Pharmacol 116:2549-2556.
25. Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J, Chapman H, Henson SM, Berge JM, Dean DK, Kotecha NR, Morgan HKA, Rami HK, Ward RW, Thompson M, Wilson S, Smith SA, Cawthorne MA, Stock MJ and Arch JRS (1998) The contribution of classical (beta-1/2) and atypical beta adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta-3 adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther 285:1084-1095.
26. Strosberg D and Rietri-Rouxel F (1996) Function and regulation of β3-adrenoceptor. Trends Pharmacol Sci 17:373-381.
27. Van Rossum JM (1963) Cumulative dose-response curves. 2. The technique for the making of dose response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299-330.
28. Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O and Ajisawa Y (1998) Species differences in the distribution of β-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124:593-599.